As a first‐line therapy for Helicobacter pylori, dual therapy with vonoprazan and amoxicillin (VA‐dual) provides an eradication rate similar to that of vonoprazan‐based triple therapy. As the factors associated with the eradication rate of H. pylori with VA‐dual are unknown,we investigated them in this study.

中文翻译：

---

体型对使用沃诺拉赞和阿莫西林双重治疗一线根除幽门螺杆菌成功的影响

作为幽门螺杆菌的一线疗法，沃诺拉赞和阿莫西林（VA-dual）的双重治疗提供了与基于沃诺拉赞的三联疗法相似的根除率。由于与 VA-dual幽门螺杆菌根除率相关的因素尚不清楚，我们在本研究中对其进行了调查。